IP Library Granted Patent US 10,064,892
Granted Patent B2
US 10,064,892 · App. 14/904,676 · Granted Sep 4, 2018

Method for producing an osteoinductive calcium phosphate and products thus obtained

Inventors: Florence De Groot-Barrere (Bilthoven, NL); Vincent Van Miegem (Bilthoven, NL); Huipin Yuan (Bilthoven, NL); Joost De Bruijn (Bilthoven, NL)
Assignee: KUROS BIOSCIENCES B.V.
A61K33/42A61K9/14A61L27/12A61L27/32A61L27/56A61L2400/12A61L2400/18A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,064,892
App. No.
14/904,676
Granted
Sep 4, 2018
Kind
B2
Abstract

The invention relates to a method for producing an osteoinductive calcium phosphate material, the method comprising the steps of providing a sintered calcium phosphate starting material having a surface topography consisting of calcium phosphate grains, subjecting the sintered calcium phosphate starting material to a hydrothermal treatment of between 125-150° C. for a duration sufficient to change calcium phosphate grains on the surface of the starting material into calcium phosphate needles.

Claims (10)

1. A method for producing an osteoinductive calcium phosphate material, the method comprising the steps of:

providing a sintered biphasic calcium phosphate (BCP) starting material comprising β-tricalcium phosphate (βTCP) and 4-20 wt. % of hydroxyapatite (HA), the sintered BCP starting material having a surface topography consisting of calcium phosphate grains, and

subjecting the sintered BCP starting material to hydrothermal treatment at a temperature equal to or higher than 125° C. for a duration sufficient to change calcium phosphate grains on the surface of the starting material into HA needles, to obtain said osteoinductive calcium phosphate material.

2. Method according to claim 1 , wherein the sintered BCP starting material has an average grain size in a range of 0.1-3.0 μm.

3. Method according to claim 1 , wherein the sintered BCP starting material is porous.

4. Method according to claim 1 , wherein the sintered BCP starting material comprises macropores in a size range of 50-1500 μm.

5. Method according to claim 1 , wherein the specific surface area of the osteoinductive calcium phosphate material is at least 10-50% higher than that of the BCP starting material.

6. Method according to claim 1 , wherein the protein adsorption capacity of the osteoinductive calcium phosphate material is at least 10-50% higher than that of the BCP starting material.

7. Method according to claim 5 , wherein the specific surface area of the osteoinductive calcium phosphate material is at least 80-100% higher than that of the sintered BCP starting material.

8. Method according to claim 6 , wherein the protein adsorption capacity of the osteoinductive calcium phosphate material is at least 80-100% higher than that of the sintered BCP starting material.

Assignments (2)
CHANGE OF NAME Recorded Jun 7, 2017
From: XPAND BIOTECHNOLOGY B.V.
To: KUROS BIOSCIENCES B.V.
Reel/Frame 042714/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2016
From: DE GROOT-BARRERE, FLORENCE; VAN MIEGEM, VINCENT; YUAN, HUIPIN; DE BRUIJN, JOOST
To: XPAND BIOTECHNOLOGY B.V.
Reel/Frame 037575/0656 →
Priority Claims (1)
NL 2011195 · Jul 18, 2013 · national
Continuity (1)
Related Publication 20160166610A1 · Jun 16, 2016
Cited By (1)
US 12,714,567